First time generics (Feb 2008)

1.CEFUROXIME AXETIL FOR ORAL SOLUTION (CEFTIN FOR ORAL SUSPENSION), USP 125 MG/5 ML 250 MG/5 ML RANBAXY PHARMACEUTICALS, INC. approved on 2/5/2008
2. FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE (PEPCID COMPLET) 10 MG, 800 MG, 165 MG , PERRIGO R&D COMPANY approved on 2/6/2008
3. ALENDRONATE SODIUM TABLETS USP (FOSAMAX TABLETS), 5 MG (BASE), 10 MG (BASE), AND 40 MG (BASE) FOR ONCE-DAILY DOSING; AND 35 MG (BASE) AND 70 MG (BASE) FOR ONCE-WEEKLY DOSING, TEVA PHARMACEUTICALS, Approved on 2/6/2008
4. ALENDRONATE SODIUM TABLETS USP (FOSAMAX TABLETS), 70 MG (ONCE WEEKLY) BARR LABORATORIES, INC. Approved on 2/6/2008
5. PRAMIPEXOLE DIHYDROCHLORIDE TABLETS (MIRAPEX TABLETS), 0.125 MG, 0.25 MG, 0.5 MG, 1 MG, AND 1.5 MG BARR LABORATORIES, INC. Approved on 2/19/2008
6. IRINOTECAN HYDROCHLORIDE INJECTION (CAMPTOSAR INJECTION), 20 MG/ML; PACKAGED IN 40 MG/2 ML AND 100 MG/5 ML SINGLE-USE VIALS , WATSON LABORATORIES, INC. Approved on 2/20/2008
7. CETIRIZINE HCL& PSEUDOEPHEDRINE HCL EXTENDED-RELEASE TABLETS (ZYRTEC-D EXTENDED-RELEASE TABLETS), 5 MG/120 MG, TEVA PHARMACEUTICALS USA, Approved on 2/25/2008
8. CALCIUM ACETATE CAPSULES (PHOSLO GELCAPS), 667 MG (EQUIVALENT TO 169 MG CALCIUM), ROXANE LABORATORIES, INC. Approved on 2/26/2008
9. GRANISETRON HYDROCHLORIDE ORAL SOLUTION (KYTRIL ORAL SOLUTION 2 MG/10 ML), 2 MG (BASE)/10 ML, CYPRESS PHARMACEUTICAL, INC., Approved on 2/28/20